Mark Molitch works in the field of Endocrinology. He researched medicine at Perelman School of Medicine at the University of Pennsylvania. He has 4 awards "Regional Top Doctor", "Meaningful Use Stage 1 Certification", "Top MD" and "Super Doctor". Mark Molitch is a published physician. He published 15 publications, including: 'Osilodrostat, a potent oral 11-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.' Mark E. Molitch accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1255365490 | |
NPPES Provider LastName | MOLITCH | |
NPPES Provider FirstName | MARK | |
NPPES Provider ZIPCode | 606114546 | |
NPPES Provider State | IL | |
Specialty Description | Endocrinology | |
Total Claim Count | 1381.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1255365490 |
Last Name Of The Provider | MOLITCH |
First Name Of The Provider | MARK |
View All |
Dr. Lewis Landsberg, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Robert M. Sargis, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Maxfield P. Flynn, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Grazia Aleppo, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Alexandra M. Dumitrescu, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Nancy F. Gamarra, MD
This Doctor is OpenDoctor Recommended. |